PureTech Health plc announced the appointment of Sharon Barber-Lui, MBA, CPA, to its board of directors as a non-executive director and as a member of the Audit Committee. She previously led U.S. Oncology Portfolio Market Strategy, Operations and Business Analytics at Merck & Co. Inc. During her two decades at Merck & Co.

Inc., Ms. Barber-Lui has held multiple financial and operational positions of increasing responsibility, including Chief Financial Officer of U.S. Oncology, Director of U.S. Treasury Operations and regional Treasurer of Asia Pacific. She currently serves as the Senior Vice President of Global Finance at EQRx. On joining the board, Ms. Barber-Lui will become a member of the board's Audit Committee, and she will become chair of that committee immediately following the Company's announcement of its 2021 full-year financial results.

At that time, Mr. Viehbacher will step down from his role as chair of the board's Audit Committee but will remain a member of the committee. Dr. Raju Kucherlapati and Dame Marjorie Scardino will also continue as members of the Audit Committee.